Atypical motor and behavioral presentations of Alzheimer disease a case-based approach

Neurologist

Volumn 18, Issue 5, 2012, Pages 266-272

  Duker, Andrew P ^a   Espay, Alberto J ^a   Wszolek, Zbigniew K ^b   Rademakers, Rosa ^c   Dickson, Dennis W ^c   Kelley, Brendan J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

Alzheimer disease; Corticobasal syndrome; Frontal variant Alzheimer disease; Logopenic progressive aphasia; Posterior cortical atrophy

Indexed keywords

CARBIDOPA; LEVODOPA;

ADULT; AGED; ALZHEIMER DISEASE; APHASIA; APRAXIA; ATTENTION DISTURBANCE; BEHAVIOR; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; COORDINATION DISORDER; CORTICOBASAL DEGENERATION; DYSPHAGIA; DYSTONIA; EXECUTIVE FUNCTION; HUMAN; MALE; MOTOR ACTIVITY; MYOCLONUS; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; REVIEW; SON;

AGED; AGNOSIA; ALZHEIMER DISEASE; APHASIA; APRAXIAS; BRAIN; DYSTONIA; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PARKINSONIAN DISORDERS; SYNDROME;

EID: 84865987652     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e3182675376     Document Type: Review

References (47)

1. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2006;366:2112-2117.
2. Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging. 1995;16:271-278.
3. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263-269.
4. Rebeiz JJ, Kolodny EH, Richardson EP. Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. Trans Am Neurol Assoc. 1967;92:23-26.
5. Boeve BF, Maraganore DM, Parisi JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology. 1999;53:795-800.
6. Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006;66:41-48.
7. Cordato NJ, Halliday GM, McCann H, et al. Corticobasal syndrome with tau pathology. Mov Disord. 2001;16:656-667.
8. Lang AE. Corticobasal degeneration: selected developments. Mov Disord. 2003;18(suppl 6):S51-S56.
9. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology. 1997;48:119-125.
10. Massman PJ, Kreiter KT, Jankovic J, et al. Neuropsychological functioning in cortical-basal ganglionic degeneration: differentiation from Alzheimer's disease. Neurology. 1996;46:720-726.
11. Yamauchi H, Fukuyama H, Nagahama Y, et al. Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration. Arch Neurol. 1998; 55:609-614.
12. Hauser RA, Murtaugh FR, Akhter K, et al. Magnetic resonance imaging of corticobasal degeneration. J Neuroimaging. 1996;6: 222-226.
13. Josephs KA, Tang-Wai D, Edland SD, et al. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Arch Neurol. 2004; 61:1881-1884.
14. Murray ME, Graff-Radford NR, Ross OA, et al. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 2011;10:785-796.
15. Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol. 2002;61:935-946.
16. Doran M. Pathological heterogeneity of clinically diagnosed corticobasal degeneration. J Neurol Sci. 2003;216:127-134.
17. Chand P, Grafman J, Dickson D, et al. Alzheimer's disease presenting as corticobasal syndrome. Mov Disord. 2006;21: 2018-2022.
18. Alladi S, Xuereb J, Bak T, et al. Focal cortical presentations of Alzheimer's disease. Brain. 2007;130:2636-2645.
19. Imamura A, Wszolek ZK, Lucas JA, et al. Corticobasal syndrome with Alzheimer's disease pathology. Mov Disord. 2009;24: 152-153.
20. Okazaki K, Fu Y, Nishihira Y, et al. Alzheimer's disease: report of two autopsy cases with a clinical diagnosis of corticobasal degeneration. Neuropathology. 2010;30:140-148.
21. Hu WT, Rippon GW, Boeve BF, et al. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord. 2009;24:1375-1379.
22. Johnson JK, Head E, Kim R, et al. Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol. 1999;56:1233-1239.
23. Habek M, Hajnsek S, Zarkovic K, et al. Frontal variant of Alzheimer's disease: clinico-CSF-pathological correlation. Can J Neurol Sci. 2010;37:118-120.
24. Larner AJ. "Frontal variant Alzheimer's disease": a reappraisal. Clin Neurol Neurosurg. 2006;108:705-708.
25. Talbot K. A frontal variant of Alzheimer's disease exhibits decreased calcium-independent phospholipase A2 activity in the prefrontal cortex. Neurochem Int. 2000;37:17-31.
26. Woodward M, Jacova C, Black SE, et al. Differentiating the frontal variant of Alzheimer's disease. Int J Geriatr Psychiatry. 2010;25:732-738.
27. Back-Madruga C, Boone KB, Briere J, et al. Functional ability in executive variant Alzheimer's disease and typical Alzheimer's disease. Clin Neuropsychol. 2002;16:331-340.
28. Taylor KI, Probst A, Miserez AR, et al. Clinical course of neuropathologically confirmed frontal-variant Alzheimer's disease. Nat Clin Pract Neurol. 2008;4:226-232.
29. Kelley BJ, Boeve BF, Josephs KA. Cognitive and noncognitive neurological features of young-onset dementia. Dement Geriatr Cogn Disord. 2009;27:564-571.
30. Boesenberg C, Schulz-Schaeffer W, Meissner B, et al. Clinical course in young patients with sporadic Creutzfeldt-Jakob disease. Ann Neurol. 2005;58:533-543.
31. Benson DF, Davis RJ, Snyder BD. Posterior cortical atrophy. Arch Neurol. 1988;45:789-793.
32. Mendez MF, Ghajarania M, Perryman KM. Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer's disease. Dement Geriatr Cogn Disord. 2002;14:33-40.
33. Tang-Wai D, Graff-Radford N, Boeve BF, et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology. 2004;63:1168-1174.
34. Chan D, Crutch SJ, Warrington EK. A disorder of colour perception associated with abnormal colour after-images: a defect of the primary visual cortex. J Neurol Neurosurg Psychiatr. 2001;71:515-517.
35. Duffy C. Cortical motion blindness in visuospatial AD. Neurobiol Aging. 2000;21:867-869.
36. McMonagle P, Deering F, Berliner Y, et al. The cognitive profile of posterior cortical atrophy. Neurology. 2006;66:331-338.
37. Renner JA, Burns JM, Hou CE, et al. Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology. 2004;63: 1175-1180.
38. Hof P, Vogt B, Bouras C, et al. Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways. Vision Res. 1997;37:3609-3625.
39. Gorno-Tempini M, Dronkers NF, Rankin KP, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 2004;55:335-346.
40. Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011; 76:1006-1014.
41. Forman MS, Farmer J, Johnson JK, et al. Frontotemporal dementia: clinicopathological correlations. Ann Neurol. 2006; 59:952-962.
42. Gorno-Tempini M, Brambati SM, Ginex V, et al. The logopenic/ phonological variant of primary progressive aphasia. Neurology. 2008;71:1227-1234.
43. Amici S, Gorno-Tempini M, Ogar JM, et al. An overview on primary progressive aphasia and its variants. Behav Neurol. 2006;17:77-87.
44. Josephs KA, Whitwell JL, Duffy JR, et al. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology. 2008;70:25-34.
45. Josephs KA, Duffy JR, Fossett TR, et al. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants. Arch Neurol. 2010; 67:596-605.
46. Mesulam M, Wicklund A, Johnson N, et al. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol. 2008;63:709-719.
47. Grossman M. Primary progressive aphasia: clinicopathological correlations. Nat Rev Neurol. 2010;6:88-97.